These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8281712)

  • 21. Randomised crossover trial to assess the tolerability of LHRH analogue administration.
    Williams G; Lindsay S; Bowsher WG
    Prostate Cancer Prostatic Dis; 2003; 6(2):187-9. PubMed ID: 12806381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does preoperative treatment with a gonadotropin-releasing hormone agonist improve the outcome of endometrial resection?
    Vercellin P; Perin A; Consonn R; Oldan S; Parazzini F; Crosignani PG
    J Am Assoc Gynecol Laparosc; 1998 Nov; 5(4):357-60. PubMed ID: 9782138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Goserelin ('Zoladex')--offering patients more choice in early breast cancer.
    Mitchell H
    Eur J Oncol Nurs; 2004; 8 Suppl 2():S95-103. PubMed ID: 15590321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-operative endometrial thinning agents before hysteroscopic surgery for heavy menstrual bleeding.
    Sowter MC; Singla AA; Lethaby A
    Cochrane Database Syst Rev; 2000; (2):CD001124. PubMed ID: 10796747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia.
    Fraser IS; Healy DL; Torode H; Song JY; Mamers P; Wilde F
    Obstet Gynecol; 1996 Apr; 87(4):544-50. PubMed ID: 8602306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corona stenting in a patient menorrhagia: use of a gonadotrophin releasing hormone agonist to facilitate anticoagulation.
    Khurana C; Taylor P; de Belder MA
    Int J Cardiol; 1998 Jan; 63(1):89-91. PubMed ID: 9482151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised trial comparing the safety and efficacy of the Zoladex 10.8-mg depot, administered every 12 weeks, to that of the Zoladex 3.6-mg depot, administered every 4 weeks, in patients with advanced prostate cancer. The Dutch South East Cooperative Urological Group.
    Dijkman GA; Debruyne FM; Fernandez del Moral P; Plasman JW; Hoefakker JW; Idema JG; Sykes M
    Eur Urol; 1995; 27(1):43-6. PubMed ID: 7744141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new long acting formulation of the luteinizing hormone-releasing hormone analogue goserelin: results of studies in prostate cancer.
    Debruyne FM; Dijkman GA; Lee DC; Witjes WP; del Moral F; Karthaus HF; van der Mejden AP; Plasman JW; Pull HC; Kums JJ; Idema JG; Hoefakker JW; Heijbroek RP; Kil PJ; Khoe GS
    J Urol; 1996 Apr; 155(4):1352-4. PubMed ID: 8632572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-risk endometrial hyperplasia: hysteroscopy and histologic evaluation after treatment with LH-RH analogue.
    Pace S; Figliolini M; Grassi A; Franceschini P; Pachì A
    Clin Exp Obstet Gynecol; 1994; 21(2):79-86. PubMed ID: 8070121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of pelvic endometriosis with goserelin, an LHRH agonist].
    Ventruba P; Crha I; Müller P; Mlyncek M
    Ceska Gynekol; 1996 Feb; 61(1):11-6. PubMed ID: 8624587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding.
    Vilos GA; Oraif A; Vilos AG; Ettler H; Edris F; Abu-Rafea B
    J Minim Invasive Gynecol; 2015 Jan; 22(1):66-77. PubMed ID: 25048567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methods and efficacy of medical and surgical treatment of non functional menorrhagia].
    Brun JL; André G; Descat E; Creux H; Vigier J; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S368-83. PubMed ID: 19268216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders.
    Perry CM; Brogden RN
    Drugs; 1996 Feb; 51(2):319-46. PubMed ID: 8808170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of hysteroscopy in the diagnosis and follow-up of endometrial hyperplasia].
    Gubbini G; Filoni M; Linsalata I; Stagnozzi R; Stefanetti M; Marabini A
    Minerva Ginecol; 1998 Apr; 50(4):125-33. PubMed ID: 9691636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness and tolerance of depot leuprorelin acetate for preoperative endometrium flattening before endometrial ablation. German Leuprorelin Study Group].
    Römer T; Deckardt R; Lobodasch K; Bernau M; Kemnitz J; Dewitt E; Koepcke E; Bethge HC; Kienle E; Hillger H; Wallwiener D
    Zentralbl Gynakol; 2000; 122(10):519-24. PubMed ID: 11072686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The place of Zoladex in deferred surgery for uterine fibroids. Zoladex Myoma Study Group.
    Gerris J; Degueldre M; Peters AA; Romao F; Stjernquist M; al-Taher H
    Horm Res; 1996; 45(6):279-84. PubMed ID: 8793522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase III randomized trial comparing the efficacy and safety of the 3-monthly 10.8-mg depot of Zoladex with the monthly 3.6-mg depot in patients with advanced prostate cancer. Dutch South East Cooperative Urological Group.
    Dijkman GA; Debruyne FM; Fernandez del Moral P; Plasman JW; Hoefakker JW; Idema JG; Sykes M
    Eur Urol; 1994; 26 Suppl 1():1-2. PubMed ID: 7737253
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical efficacy of goserelin (Zoladex) in the treatment of uterine myomas in infertile patients.
    Kopitović V; Bujas M; Fistes Topalski N; Pjević M; Ilić D; Kapamadzija A; Bujas I
    Med Pregl; 2001; 54(7-8):339-46. PubMed ID: 11905182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and therapy of low-risk endometrial hyperplasia. Experience with LH-RH-A].
    Pace S; Stentella P; Frega A; Palazzetti PL; Nobili F; Figliolini M; Grassi A
    Minerva Ginecol; 1992 Dec; 44(12):645-51. PubMed ID: 1491773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.